Abstract
Abstract Background The purpose of this study was to stratify risk subgroups for mechanical ventilation in adults presenting with encephalitis. Methods A retrospective observational study of 271 adults ( > 18 years old) admitted with an encephalitis diagnosis according to International Encephalitis Consortium guidelines were enrolled from sixteen hospitals in Houston, Texas between the years of 2005 and 2015. Results Mechanical ventilation (MV) was utilized in 91/271 (33.6%) adults with encephalitis and it was associated in hospital mortality (24.2% vs 3.9%, P< 0.001). There were no significant differences in age, race, gender, underlying comorbidities or immunosuppressive conditions, fever, symptoms on presentation, focal neurological deficits, Glasgow coma scale, CSF profile, and abnormal cranial imaging including cerebral edema between patients with or without MV (P >0.05). Risk factors associated with the need for MV included seizures, serum white blood cell (WBC) counts >11,000/mm3, a Sequential Organ Failure Assessment (SOFA) score >3 and abnormal Electroencephalogram (EEG) (P< 0.05). A risk model was created using 3 baseline variables independently associated with MV (P< 0.05): serum WBC count >11,000/mm3, a SOFA >3 and abnormal EEG. The risk score classified patients into 3 subgroups for the need for MV: low risk [none of the three variables, 1/32 (3.1%)], intermediate risk [1 of the 3 variables, 19/106 (17.9%], and high risk [2 or 3 of the 3 variables, 71/136 (52.2%)]. Risk Classification for Mechanical Ventilation in Patients with Encephalitis. a Predictors include white blood cell count > 11, Sequential Organ Failure Assessment (SOFA) scores > 3 or abnormal Electroencephalogram (EEG) Receiver Operating Characteristic (ROC) curve of risk score (Low =0 variables seen in the patients, Intermediate = 1 variable seen, and High = 2 or 3 variables seen). Area under the curve = 0.728. Conclusion This risk score can be utilized by clinicians to assess the need for MV in adults presenting with encephalitis to help stratify patients that require intensive care unit admissions. Disclosures Rodrigo Hasbun, MD MPH FIDSA, Biofire: Grant/Research Support|Biofire: Honoraria.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.